 |
市场调查报告书
商品编码
1567234
脱髮和脱髮处方药市场：按药物类型、性别、应用、给药途径、地区Prescription Hair Loss and Hair Removal Drugs Market, By Drug Type, By Gender, By Application, By Route of Administration, By Geography |
||||||
预计2024年全球脱髮和脱髮处方药市场规模为301亿美元，预计2031年将达到481.1亿美元，2024年至2031年复合年增长率为6.9%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 301亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024年至2031年 |
| 预测 2024-2031 年复合年增长率： | 6.90% | 2031年价值预测 | 481.1亿美元 |
全球脱髮和脱髮处方药市场的成长主要是由容易出现脱髮问题的老年人口不断增加所推动的。此外，学名药的容易取得以及消费者对各种脱髮治疗方案的认识不断提高也推动了市场的成长。然而，与长期使用这些药物相关的副作用以及替代治疗方法的可用性可能会给行业参与者带来挑战。
市场动态：
全球脱髮和脱髮处方药市场的成长是由脱髮症、雄性脱髮症和其他导致脱髮的疾病患病率上升等因素推动的。此外，越来越多的老年人面临头髮稀疏和秃头的高风险，也将成为市场成长的驱动力。活性化研发活动，推出解决特定性别掉髮问题的新产品，发挥重要作用。然而，包括植髮手术、假髮和接髮在内的替代脱髮治疗方法的可用性可能会阻碍市场成长。此外，长期使用脱髮药物带来的性副作用、忧郁症和心臟病等副作用可能会阻碍市场成长。亚太地区和拉丁美洲的新兴市场为产品渗透提供了有利可图的机会。
本研究的主要特点
该报告对全球脱髮和脱髮处方药市场进行了深入分析，包括以2023年为基础的预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%）年发布。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、业绩和策略等参数对全球脱髮和脱髮处方药市场的主要企业进行了分析。
主要企业包括默克、强生、宝洁、欧莱雅、联合利华、大正製药、乐敦製药、资生堂、Lifes2Good 等。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球处方除毛和除毛产品市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球脱髮和脱髮处方药市场的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章 市场动态、法规与趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球脱髮和脱髮处方药市场 - 冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球脱髮和脱髮处方药市场，按药物类型，2019-2031
- 脱髮治疗
- 口服避孕药
- 除毛药
第六章全球脱髮和脱髮处方药市场，性别，2019-2031
- 男性
- 女士
第七章 全球脱髮和脱髮处方药市场，按应用分类，2019-2031
- 慢性脱髮症
- 急性脱髮症
第八章全球脱髮和脱髮处方药市场，依给药途径，2019-2031
- 外用
- 口服
- 注射
第9章全球脱髮和脱髮处方药市场，按分销管道，2019-2031
- 医院药房
- 零售药房
- 网路药房
第10章全球脱髮和脱髮处方药市场，按地区，2019-2031
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第十一章竞争格局
- 公司简介
- Pfizer Inc.
- Merck &Co., Inc.
- Johnson &Johnson
- Bausch Health Companies Inc.
- L'Oreal SA
- Galderma SA
- Revivogen
- Hims, Inc.
- Evolus, Inc.
- Aclaris Therapeutics, Inc.
- Amgen Inc.
- Sientra, Inc.
- Dr. Reddy's Laboratories Ltd.
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Mylan NV
- Zynerba Pharmaceuticals, Inc.
- Apex Therapeutics, LLC
第十二章分析师建议
第十三章 参考文献与调查方法
- 参考
- 调查方法
Global prescription hair loss and hair removal drugs market is estimated to be valued at USD 30.10 Bn in 2024 and is expected to reach USD 48.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 30.10 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 6.90% | 2031 Value Projection: | US$ 48.11 Bn |
Prescription hair loss refers to the loss of hair from the scalp or other parts of the body that occurs due to aging, hormonal changes, medical conditions, stress or genetic predisposition. Global prescription hair loss and hair removal drugs market growth is driven primarily by rising geriatric population who are more prone to hair fall issues. Furthermore, easy availability of generic drugs coupled with growing consumer awareness about various treatment options for hair loss can also drive the market growth. However, side effects associated with prolonged usage of these drugs and availability of alternative treatments can pose challenges to industry players.
Market Dynamics:
Global prescription hair loss and hair removal drugs market growth is driven by factors like rising prevalence of alopecia areata, androgenic alopecia and other medical conditions causing hair loss. Growing geriatric population who are at an increased risk of suffering from hair thinning and balding can also drive the market growth. Rising R&D activities leading to new product launches catering to gender-specific hair loss issues plays a crucial role. However, factors such as availability of alternative hair loss treatments including hair transplant surgery, wigs and hair extensions can hamper the market growth. Moreover, side effects associated with long term use of hair loss drugs such as sexual side effects, depression and heart issues can hamper the market growth. Emerging markets in Asia Pacific and Latin America present lucrative opportunities for product penetration.
Key features of the study:
This report provides in-depth analysis of the global prescription hair loss and hair removal drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prescription hair loss and hair removal drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck, Johnson & Johnson, Procter & Gamble, L'Oreal, Unilever, Taisho Pharmaceuticals, Rohto Pharmaceutical, Shiseido, and Lifes2Good
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global prescription hair loss and hair removal drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prescription hair loss and hair removal drugs market
Detailed Segmentation-
- By Drug Type Insights (Revenue, USD Bn, 2019 - 2031)
- Hair Loss Medications
- Oral Contraceptive Pills
- Hair Removal Medications
- By Gender Insights (Revenue, USD Bn, 2019 - 2031)
- Male
- Female
- By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Chronic Hair Loss
- Acute Hair Loss
- By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Topical
- Oral
- Injectable
- By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
- By Regional Insights (Revenue, USD Bn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- Bausch Health Companies Inc.
- L'Oreal S.A.
- Galderma S.A.
- Revivogen
- Hims, Inc.
- Evolus, Inc.
- Aclaris Therapeutics, Inc.
- Amgen Inc.
- Sientra, Inc.
- Reddy's Laboratories Ltd.
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Mylan N.V.
- Zynerba Pharmaceuticals, Inc.
- Apex Therapeutics, LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Gender
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Prescription Hair Loss and Hair Removal Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Prescription Hair Loss and Hair Removal Drugs Market, By Drug Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hair Loss Medications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oral Contraceptive Pills
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hair Removal Medications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Prescription Hair Loss and Hair Removal Drugs Market, By Gender, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Male
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Female
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Prescription Hair Loss and Hair Removal Drugs Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Chronic Hair Loss
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Acute Hair Loss
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Prescription Hair Loss and Hair Removal Drugs Market, By Route of Administration, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Prescription Hair Loss and Hair Removal Drugs Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
10. Global Prescription Hair Loss and Hair Removal Drugs Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Company Profiles
- Pfizer Inc.
- Company Highlights
- Gender Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Johnson & Johnson
- Bausch Health Companies Inc.
- L'Oreal S.A.
- Galderma S.A.
- Revivogen
- Hims, Inc.
- Evolus, Inc.
- Aclaris Therapeutics, Inc.
- Amgen Inc.
- Sientra, Inc.
- Dr. Reddy's Laboratories Ltd.
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Mylan N.V.
- Zynerba Pharmaceuticals, Inc.
- Apex Therapeutics, LLC
- Pfizer Inc.
12. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
脱髮治疗产品市场－全球产业规模、份额、趋势、机会和预测（按产品类型、按最终用户、按配销通路、按地区和竞争情况，2020-2030 年）
脱髮治疗产品市场：按产品、性别、分销管道和最终用户 - 2025-2030 年全球预测
脱髮治疗产品市场：依产品类型、通路和地区，2024年至2031年雷射除毛治疗市场：按雷射类型、最终用途划分 - 2025-2030 年全球预测
雷射除毛治疗的全球市场（2024-2028）
全球脱髮治疗产品市场，2024-2028
全球脱髮治疗产品的市场评估：依产品类型、依成分、依应用、依价格、依类别、依最终用户、依分销渠道、依地区、机会、预测（2017-2031）
脱髮治疗市场：按产品类型、按给药途径、按性别、按配销通路、按地区
脱髮治疗的全球市场 (2019-2029年):各类型、性、终端用户、地区的市场规模、占有率、趋势分析、机会、预测